Your new experience awaits. Try the new design now and help us make it even better

CASE REPORT article

Front. Oncol.

Sec. Gastrointestinal Cancers: Gastric and Esophageal Cancers

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1560011

This article is part of the Research TopicPrimary and Secondary Chemotherapy Resistance in Gastrointestinal Tumors: Key Mechanisms and Ways to Overcome ResistanceView all 11 articles

Small bowel metastasis during organ preservation in esophageal squamous cell carcinoma patients:case report and literature review

Provisionally accepted
Qinxing  CaoQinxing Cao1,2Hejiang  LuHejiang Lu1,3Liangbo  NiuLiangbo Niu4Xioafang  ZhaoXioafang Zhao5Yan  LiYan Li4Yisha  LiuYisha Liu4Minghui  PangMinghui Pang3,4*
  • 1Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China
  • 2Department of Gastrointestinal surgery, First People's Hospital of Yibin, Sichuan, China
  • 3Department of Gastrointestinal surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China
  • 4Department of Geriatric General Surgery, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China
  • 5Department of Radiology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China

The final, formatted version of the article will be published soon.

Background: For patients with locally advanced esophageal squamous cell carcinoma (ESCC) who achieve a clinical complete response (cCR) after comprehensive treatment, organ preservation and observation-waiting strategies provide a more conservative treatment option that enhances the patient's quality of life. The high cCR rate of chemoradiotherapy combined with immunotherapy is driving the shift in ESCC treatment from traditional radical surgery to organ preservation.We report a case of a 57-year-old male patient diagnosed with esophageal ESCC who underwent combined radiotherapy, chemotherapy, and immunotherapy. After treatment, the patient achieved a cCR, resulting in 15 months of progression-free survival. At this stage, the primary lesion showed no signs of local regrowth or recurrence; however, unexpected metastasis to the small intestine occurred, leading to bowel obstruction. The metastasis at this occult site was not detected by sensitive monitoring methods, and the side effects of the immunotherapy drugs further complicated the diagnosis and differential diagnosis. The tumor metastasis at the unexpected site was not identified early, but following rescue surgery, the patient survived for an additional 6 months.Organ-preserving surgery for esophageal cancer significantly improves patients' short-term quality of life. However, due to incomplete monitoring measures, a cautious approach should be maintained when implementing organ-preserving surgery at this stage. For patients undergoing organ-preserving surgery, continuous active monitoring is essential. Timely intervention should be provided when clinical symptoms arise, and personalized treatment plans should be developed, while remaining vigilant for metastasis at unexpected sites.

Keywords: esophageal squamous cell carcinoma, Small bowel metastasis, clinical complete response, Watch-and-wait, Organ-preserving treatment

Received: 13 Jan 2025; Accepted: 30 Jun 2025.

Copyright: © 2025 Cao, Lu, Niu, Zhao, Li, Liu and Pang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Minghui Pang, Department of Gastrointestinal surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.